Vascular Access Devices Market Size, Share & Industry | 2031

Report Description

Global Vascular Access Devices Market Outlook 2032

The global vascular access devices market size was USD 7,349.5 Million in 2022 and is likely to reach USD 14,211.5 Million by 2031, expanding at a CAGR of 7.8% during 2022–2031. The growing prevalence of lifestyle diseases and growing demand for minimally invasive procedure is propelling the demand for vascular access devices during the forecast period.

A vascular access device (VAD) is a medical device used to provide access to a patient's veins for the delivery of intravenous (IV) medications, infusion therapy, and extracorporeal therapies like apheresis. The various types of VADs include peripheral venous catheters (PVCs), central venous catheters (CVCs), peripherally inserted central catheters (PICCs), and implanted ports.

Get Free Sample Report

Moreover, these devices can be short-term or long-term, and their choices depend on the duration of medication administration, the patient's anatomy, and the setting. VADs are essential for patients who require prolonged treatment, such as chemotherapy, and can reduce the discomfort and stress of repeated needle sticks.

The COVID-19 pandemic burdened the world economy, increased dependency among nations, and presented challenges to national governments. It caused production challenges and prompted concerns among economies and businesses. The demand for CVCs, particularly antimicrobial ones, surged due to the high need for vascular access in critically ill COVID-19 patients. Thus, this segment witnessed a temporary increase in sales during the COVID. Moreover, the heightened focus on preventing hospital-acquired infections during the pandemic led to a rise in the demand for catheters with antimicrobial properties.

However, COVID-19 affected the need for medical equipment in several ways. While the demand for the devices used to treat COVID-19 patients in intensive care increased, the demand for other devices suffered due to delayed or canceled treatments.

According to the study titled ‘The impact of the COVID-19 pandemic on vascular surgery: Health care systems, economic, and clinical implications’ published in the National Library of Medicine in July 2021, in ambulatory care and outpatient clinics, 89.2% of vascular surgeons reported changes to their practice. Clinical volume declined by 96.5%, surgical volume declined by 71.7%, and the daily number of inpatient consultations reduced to just 1.81 per day.

Global Vascular Access Devices Market Dynamics

Major Drivers: Growing Prevalence of Lifestyle Diseases

According to the report published by the World Health Organization in 2021, cardiovascular diseases or CVDs are one of the major causes of death across the globe. About 17.9 million deaths or 32% of all deaths worldwide in 2019 caused by CVDs. Out of these deaths, 85% were caused by heart attack and stroke.

According to the World Heart Federation Vision 2030, the number of CVD deaths is projected to rise from an estimated 18.9 million in 2020 to over 22.2 million in 2030 and 32.3 million in 2050.

The number of patients suffering from chronic kidney disease (CKD) is expected to increase in the coming years, with the growing prevalence of diabetes, as diabetes is a major risk factor for CKD. The growing prevalence of these lifestyle diseases, particularly CKD and CVDs, is expected to contribute to the vascular access devices market growth, as tunneled and non-tunneled catheter devices are widely used in dialysis procedures and the treatment of various cardiovascular diseases.

Major Drivers: Growing Demand for Minimally Invasive Procedure

Minimally invasive surgery typically involve smaller incisions or entry points compared to traditional open surgeries. This leads to reduced pain and discomfort for patients, making such procedures favorable.

Several benefits of minimally invasive procedures include few incisions, low risk of infection, and a quick recovery period. However, physicians recommend minimally invasive procedures to treat chronic disorders. Thus, the adoption of these surgeries is increasing. For instance, according to the article published in the Annals of Medicine and Surgery Journal in October 2021, multiple facets of the conventional surgical method have been replaced by minimally invasive surgery (MIS) in recent years, while gaining interest due to improved survival, fewer complications, and rapid recovery. Therefore, an increasing number of MIS is anticipated to propel the market in the coming years.

Existing Restraints: High Costs

Vascular access devices are expensive and the price of these devices changes according to the type of vascular access device (VAD) used in a procedure. The price of these devices ranges from USD 150 to USD 900 on average.

The cost to the physician for inserting a VAD range from USD 20 to USD 90 per hour. Vascular access treatments are expensive when a patient is admitted to the hospital, and complications such as occlusions or central catheter bloodstream infections drive up the cost of the procedure significantly.

According to the Canadian Association of Nurses in Oncology, in the US, a central catheter bloodstream infection increases the procedure price to more than USD 25,000. This high placement and maintenance price for vascular access devices (VADs) are expected to restrain the market during the forecast period.

Emerging Opportunities: Technological Advancements

Advances in material science, engineering, and manufacturing techniques have led to the development of vascular access devices with enhanced performance characteristics, such as increased durability, flexibility, and resistance to occlusion and infection.

Innovative design features, such as catheter coatings, antimicrobial properties, and needleless connectors, improve patient comfort and safety by reducing the risk of complications, such as infections and thrombosis, associated with vascular access devices.

Technological innovations enable the use of minimally invasive insertion techniques, such as ultrasound-guided and fluoroscopy-assisted procedures, which result in less trauma, faster recovery times, and reduced healthcare costs compared to traditional insertion methods.

Scope of the Global Vascular Access Devices Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Market Segment Insights

Product Type Segment Analysis

Based on product type, the global vascular access devices market is segmented into peripheral, central, and accessories.

The peripheral segment held a 40.3% share of the market in 2022 and is expected to expand at a CAGR of 8.4% during the forecast period. Peripheral vascular access devices such as peripheral intravenous catheters (PIVC) are generally easier and quicker to insert as compared to central devices such as central venous catheters (CVC). This makes them suitable for situations where rapid access to the circulatory system is needed, such as emergency departments or outpatient settings.

Get Free Sample Report

Lumen Type (PICC) Segment Analysis

Based on lumen type (PICC), the global vascular access devices market is segregated into single lumen, dual lumen, and triple lumen.

The single lumen segment held 27.1% share of the market in 2022 and is expected to expand at a CAGR of 9.0% during the forecast period. Single-lumen PICCs have a simpler design with only one lumen, reducing the risk of mechanical complications such as kinking, occlusion, or malfunction than multi-lumen catheters. Moreover, each additional lumen in a multi-lumen PICC increases the surface area exposed to potential contamination and colonization by bacteria, raising the risk of catheter-related bloodstream infections (CRBSIs). Single-lumen PICCs have a low risk of infection due to their simple design.

Get Free Sample Report

Dimensions (PICC) Segment Analysis

Based on dimensions (PICC), the global vascular access devices market is divided into 1-Fr, 1.9-Fr, 3-Fr, 4-Fr, 5-Fr, 6-Fr, and Others.

The 1-Fr segment held an XX% share of the market in 2022 and is expected to expand at a CAGR of XX% during the forecast period. One of the primary reasons for the preference for 1 Fr dimension PICC catheters is their sustainability for pediatric patients, especially neonates and infants. These patients have small veins, making it challenging to insert larger catheters. The small diameter of a 1 Fr PICC reduces the risk of vein trauma and provides improved fit for these patients.

Patient Type (PICC) Segment Analysis

Based on patient type (PICC), the global vascular access devices market is bifurcated into kids and adults.

The kids segment held 48.9% share of the market in 2022 and is expected to expand at a CAGR of 7.7% during the forecast period. Ongoing advancements in pediatric medicine, more children with complex medical conditions, such as cancer, congenital heart defects, or chronic infections, are surviving into adulthood. This increases the demand for PICCs in pediatric patients, in acute care settings and for long-term management.

Manufacturers are developing specialized PICC lines tailored to the unique anatomical and physiological needs of pediatric patients. These innovations, such as small diameter catheters, improved insertion techniques, and age-appropriate designs, make PICCs safer and accessible for children, driving the kids segment.

Get Free Sample Report

Application Segment Analysis

Based on application, the global vascular access devices market is segmented into administration of fluid & nutrition, transfusion of blood products, diagnostics & testing, administration of drugs, and others.

The administration of fluid & nutrition segment held a XX% share of the market in 2022 and is expected to expand at a CAGR of XX% during the forecast period. The rising prevalence of chronic diseases such as cancer, diabetes, and kidney failure has led to an increased demand for long-term intravenous therapies, including the administration of fluids and nutrients. Vascular access devices are essential for delivering parenteral nutrition, hydration, and medication to patients with chronic conditions.

Get Free Sample Report

End-user Segment Analysis

Based on end-user, the global vascular access devices market is segmented into hospitals, ambulatory care centers, diagnostic centers, and others.

The hospital segment held a 42.5% share of the market in 2022 and is expected to expand at a CAGR of 7.8% during the forecast period. Hospitals handle a wide range of complex medical procedures as compared to ambulatory settings. These procedures often require VADs to administer fluids, medications, blood products, and nutrition directly into the bloodstream. Moreover, hospitals are equipped for emergencies where rapid access to the vascular system is crucial. VADs play a vital role in emergencies for resuscitation, blood transfusions, and delivering critical medications.

Get Free Sample Report

Mode of Insertion Segment Analysis

Based on the mode of insertion, the global vascular access devices market is bifurcated into intravenous and subcutaneous.

The intravenous segment held XX% share of the market in 2022 and is expected to expand at a CAGR of XX% during the forecast period. The increasing burden of chronic diseases such as cancer, diabetes, and kidney disease necessitate frequent medical interventions requiring frequent and prolonged IV access. For instance, according to research, 2 million people worldwide suffer from kidney failure, and the number of patients diagnosed with the disease continues to increase at a rate of 5% to 7% per year.

Get Free Sample Report

Regional Outlook

Based on region, the global vascular access devices market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America held a 32.6% share of the market in 2022 and the market in the region is expected to expand at a CAGR of 7.8% during the forecast period. Ongoing technological advancements in the region are fostering the development of innovative vascular access devices that offer improved safety, efficacy, and patient comfort. This includes the integration of features such as antimicrobial coatings, wireless connectivity, and improved materials.

The market in Asia Pacific was valued at USD XX million in 2022 and is projected to expand at a CAGR of 8.5% during the forecast period. Increased healthcare spending and infrastructure development in Asia Pacific, particularly in countries such as China, India, and Japan, are fueling the market, as patients gain access to advanced medical treatments, including vascular access procedures.

Get Free Sample Report